Sheets Smith Wealth Management Horizon Therapeutics Public LTD CO Transaction History

Sheets Smith Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$86.42 - $109.81 $307,914 - $391,253	-3,563 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$98.56 - $119.91 $394 - $479	4 Added 0.11%	3,563 $384,000
Q3 2021 Oct 15, 2021	BUY	$91.91 - $110.37 $1,838 - $2,207	20 Added 0.57%	3,559 $390,000
Q2 2021 Aug 03, 2021	BUY	$86.24 - $95.92 $305,203 - $339,460	3,539 New	3,539 $331,000
Q3 2019 Oct 28, 2019	SELL	$23.0 - $27.97 $500,618 - $608,795	-21,766 Closed	0 $0
Q2 2019 Jul 12, 2019	BUY	$22.81 - $28.48 $496,482 - $619,895	21,766 New	21,766 $524,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Sheets Smith Wealth Management with notifications on news.